These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 39566271)

  • 1. Design, synthesis, and antiproliferative activity evaluation of novel α-mangostin derivatives by ROS/MAPK signaling pathway.
    Fredimoses M; Li P; Zhang Y; Jia H; Liu S; Tian J; Nie W; Liu K; Song M; Dong Z
    Bioorg Chem; 2024 Dec; 153():107968. PubMed ID: 39566271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, and in vitro and in vivo biological evaluation of dihydroartemisinin derivatives as potent anti-cancer agents with ferroptosis-inducing and apoptosis-activating properties.
    Xu Q; Deng H; Huang X; Chen GQ; Quan YS; Wang YL; Liu JY; Yan R; Nie WZ; Shen QK; Quan ZS; Guo HY
    Eur J Med Chem; 2025 Jan; 281():117018. PubMed ID: 39488969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 5-Fluorouracil analogues versus perfluorophenyl ureas as potent anti-breast cancer agents: Design, robust synthesis, in vitro, molecular docking, pharmacokinetics ADMET analysis and dynamic simulations.
    Sroor FM; El-Sayed AF; Mahmoud K
    Bioorg Chem; 2024 Dec; 153():107944. PubMed ID: 39532011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 4-aminophenol-1,3,4-oxadiazole derivative potentiates apoptosis by targeting MAP kinase in triple negative breast cancer cells.
    Dhanalakshmi B; Anil Kumar BM; Muddenahalli Srinivasa S; Vivek HK; Sennappan M; Rangappa S; Srinivasa Murthy V
    J Biomol Struct Dyn; 2024; 42(23):13114-13129. PubMed ID: 37948299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photochemical Metal-Free synthesis and biological Assessment of isocryptolepine analogues targeting estrogen receptor Alpha in breast cancer cells.
    Bogdanov FB; Balakhonov RY; Volkov ES; Sonin IV; Andreeva OE; Sorokin DV; Piven YA; Scherbakov AM; Shirinian VZ
    Bioorg Chem; 2024 Dec; 153():107942. PubMed ID: 39515131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of flavonoid-containing compound Lupalbigenin as anti-NSCLC cancer agents via suppression of EGFR and ERK1/2 pathway.
    Cuan X; Yang X; Wang J; Sheng J; Wang X; Huang Y
    Bioorg Chem; 2024 Dec; 153():107808. PubMed ID: 39288634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biological evaluation of novel benzimidazole-derived p21-activited kinase 4 (PAK4) inhibitors bearing a 4-(4-methylpiperazin-1-yl)phenyl scaffold as potential antitumor agents.
    Hao S; Hou L; Wang JH; Yan JH; Niu YF; Cai ZH; Li F; Meng FH
    Eur J Med Chem; 2024 Dec; 280():116971. PubMed ID: 39427518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing new anticancer agents: Design, synthesis, biological evaluation and in silico study of several functionalized pyrimidine-5-carbonitriles as small molecules modulators targeting breast cancer.
    Badawi WA; Okda TM; Abd El Wahab SM; Ezz-ElDien ES; AboulWafa OM
    Bioorg Chem; 2024 Dec; 153():107953. PubMed ID: 39556931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The MAPK/ERK signaling pathway involved in Raddeanin A induces apoptosis via the mitochondrial pathway and G2 phase arrest in multiple myeloma.
    Jiang MZ; Li C; Mao CM; Yu H; Zhou YC; Pu SQ; Li RZ; Liao YJ; Zhang DY; Yang P; Li MH; Li M
    Sci Rep; 2024 Nov; 14(1):29061. PubMed ID: 39580496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New 1,3,4‒oxadiazole Quinazolines as Potential Anticancer Agents: Design, Synthesis, Biological Evaluation, and
    Gujja V; Sadineni K; Koppula SK; Basireddy A; Venkanna B; Gunda SK
    Curr Drug Discov Technol; 2025; 22(1):e090424228867. PubMed ID: 38616757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo.
    Gao J; Yin J; Li S; Jia P; Hong R; Chen J; Qu X; Zhang Z; Li M; Zhao H
    Eur J Med Chem; 2025 Jan; 281():117023. PubMed ID: 39531932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of novel diaryl urea-oxindole hybrids as BRAF kinase inhibitors targeting BRAF and KRAS mutant cancers.
    Ghannam IAY; El Kerdawy AM; Mounier MM; Abo-Elfadl MT; Abdel-Mohsen HT
    Bioorg Chem; 2024 Dec; 153():107848. PubMed ID: 39368145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel strategy to bind pyrimidine sulfonamide derivatives with odd even chains: exploration of their design, synthesis and biological activity evaluation.
    Zhou M; Liu Y; Wang S; Feng J; Ni H; Lu C; Jin G
    Mol Divers; 2024 Oct; 28(5):3011-3026. PubMed ID: 38082105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally diverse design and synthesis of novel 2-phenylindole amide derivatives with anti-canine breast cancer activity.
    Wu P; Liang X; Wang H; Wang Z; Niu Y; Dong Z; Yin L; He C; Xu F; Li H; Tang H
    Bioorg Chem; 2024 Dec; 153():107788. PubMed ID: 39265524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and structural proof of novel oxazolo[5,4-d]pyrimidine derivatives as potential VEGFR2 inhibitors. In vitro study of their anticancer activity.
    Sochacka-Ćwikła A; Regiec A; Czyżnikowska Ż; Śliwińska-Hill U; Kwiecień A; Wiatrak B; Rusak A; Krawczyńska K; Mrozowska M; Borska S; Ratajczak K; Pyra A; Mączyński M
    Bioorg Chem; 2024 Dec; 153():107958. PubMed ID: 39561438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel purine derivatives as selective CDK2 inhibitors with potential anticancer activities: Design, synthesis and biological evaluation.
    Shah A; Teraiya N; Kamdar JH; Juneja T; Sangani CB; Ahmed S; Kapadiya K
    Bioorg Chem; 2024 Dec; 153():107841. PubMed ID: 39326340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, molecular docking, and evaluation of sulfonyl quinazoline analogues as promising liver cancer drugs.
    Venkatesan G; Ping CY; Chen H; Perumal S; Karkhanis AV; Pastorin G
    Bioorg Chem; 2024 Dec; 153():107777. PubMed ID: 39244968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives as potent BET inhibitors for cancer therapy.
    Ran K; Li Y; Zhang YM; Tang DY; Chen ZZ; Xu ZG; Zhang L; Wang BC; Huang JH
    Bioorg Chem; 2024 Dec; 153():107929. PubMed ID: 39509789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis, molecular modeling and evaluation of 2,4-diaminopyrimidine analogues as promising colorectal cancer drugs.
    Venkatesan G; Yong Ping C; Chen H; Srinivasan P; Karkhanis AV; Pastorin G
    Bioorg Chem; 2024 Dec; 153():107854. PubMed ID: 39368143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biological evaluation and mechanism study of a novel indole-pyridine chalcone derivative as antiproliferative agent against tumor cells through dual targeting tubulin and HK2.
    Zheng M; Liu G; Han Y; Qian P; Wu M; Xiang M; Zhou Y
    Eur J Med Chem; 2025 Jan; 282():117058. PubMed ID: 39571460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.